Key result
Intravenous isoproterenol increased R amplitude variability significantly more in patients with panic disorder compared to normal controls.
Why the study?
Does intravenous isoproterenol increase R and T amplitude variability more in patients with panic disorder compared to normal subjects?
Case-Control (n=17)
Does intravenous isoproterenol increase R and T amplitude variability more in patients with panic disorder compared to normal subjects?
Patients with panic disorder exhibit exaggerated beat-to-beat R amplitude variability following beta-adrenergic stimulation, suggesting heightened sensitivity to sympathetic activation.
May indicate sympathetic hypersensitivity in panic disorder; hypothesis-generating and should not yet change practice.
BACKGROUND: Anxiety symptoms are associated with a marked increase in sudden cardiac death, suggesting an abnormality in cardiac autonomic function. Our previous studies show a relationship between R amplitude variability and sympathetic function. METHODS: We examined the effects of beta-adrenergic stimulation on R and T amplitude variability in panic disorder patients by infusing the beta-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects. The ECG signal was analyzed before the infusion and 5 min after the infusion was started. The outcome measures were the R and T detrended variance normalized for mean amplitudes (R(vm) and T(vm)) and the R(vi) and T(vi), measures which are normalized for the inter-beat interval variability in addition. RESULTS: Patients with panic disorder had significantly more variability in R and T amplitude than normal controls and the R amplitude variability was increased further by beta-adrenergic stimulation with isoproterenol, which was more pronounced in the patients. CONCLUSIONS: The isoproterenol-associated increase in R amplitude variability occurred in controls in the absence of significant anxiety. However, the increase in R amplitude variability was greater in patients with panic disorder, suggesting a greater sensitivity to beta-adrenergic effects of isoproterenol or to isoproterenol-induced anxiety.
No takes yet. Share an insight, caveat, or question.
Yeragani et al. (2007) conducted a case-control in Panic disorder (n=17). Intravenous isoproterenol vs. Normal subjects was evaluated on R and T detrended variance normalized for mean amplitudes (R(vm) and T(vm)) and R(vi) and T(vi). Intravenous isoproterenol increased R amplitude variability significantly more in patients with panic disorder compared to normal controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: